Core Viewpoint - The company, Giant Bio, has been actively repurchasing its shares on the Hong Kong Stock Exchange, indicating a strategy to support its stock price amid recent declines [1] Share Buyback Summary - On December 18, 2025, the company repurchased 400,000 shares at a price range of HKD 34.420 to HKD 35.040, totaling HKD 13.883 million [1] - The stock closed at HKD 34.580 on the same day, reflecting a decrease of 1.48%, with a total trading volume of HKD 179 million [1] - Since December 9, 2025, the company has conducted share buybacks for eight consecutive days, acquiring a total of 3.2 million shares for a cumulative amount of HKD 112 million [1] - During this buyback period, the stock has experienced a total decline of 5.00% [1] Buyback Details - The detailed buyback activities are as follows: - December 18: 40,000 shares at a maximum price of HKD 35.040 and a minimum price of HKD 34.420, amounting to HKD 1.3883 million [1] - December 17: 40,000 shares at a maximum price of HKD 35.220 and a minimum price of HKD 34.620, amounting to HKD 1.3971 million [1] - December 16: 40,000 shares at a maximum price of HKD 35.400 and a minimum price of HKD 34.680, amounting to HKD 1.4026 million [1] - December 15: 40,000 shares at a maximum price of HKD 35.240 and a minimum price of HKD 34.440, amounting to HKD 1.3917 million [1] - December 12: 40,000 shares at a maximum price of HKD 35.220 and a minimum price of HKD 35.000, amounting to HKD 1.4036 million [1] - December 11: 40,000 shares at a maximum price of HKD 35.360 and a minimum price of HKD 34.200, amounting to HKD 1.3888 million [1] - December 10: 40,000 shares at a maximum price of HKD 36.220 and a minimum price of HKD 35.620, amounting to HKD 1.4382 million [1] - December 9: 40,000 shares at a maximum price of HKD 36.180 and a minimum price of HKD 35.720, amounting to HKD 1.4376 million [1]
巨子生物(02367.HK)连续8日回购，累计斥资1.12亿港元